The metabolic syndrome and cardiovascular disease: Part 2

Panupong Jiamsripong, Martina Mookadam, Mohsen S. Alharthi, Bijoy K. Khandheria, Farouk Mookadam

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Abstract

In part 1 of this overview, the authors reviewed the epidemiology, definitions, pathophysiology, and interaction of inflammatory markers that are elaborated from the very active paracrine adipocyte. In part 2, they focus on the management of the metabolic syndrome. Management of this syndrome includes identification of individuals in the early stages of the syndrome and emphasizes the risk of developing diabetes mellitus and the progression to cardiovascular disease. This can be accomplished by simple physical examination and an assessment of routine laboratory findings, which should include measurement of fasting glucose, a lipid profile, and body morphometrics. A 10-year risk assessment is needed in patients who have a diagnosis of the metabolic syndrome. The most important therapeutic intervention in the metabolic syndrome is lifestyle change, with a focus on weight reduction and regular leisure time physical activity.

Original languageEnglish (US)
Pages (from-to)223-229
Number of pages7
JournalPreventive cardiology
Volume11
Issue number4
DOIs
StatePublished - 2008

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The metabolic syndrome and cardiovascular disease: Part 2'. Together they form a unique fingerprint.

Cite this